Confo Therapeutics

1 Follower

About

Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.

Christel Menet
CSO
Frank Landolt
Chief Counsel, Intellectual Property and Legal
Paolo Vicini
Chief Development Officer
Toon Laeremans
Head of Technology
Veli-Pekka Jaakola
Head of Structural Biology
Marc Moens
Head of Finance and HR
Zara Sands
Head of Computer-Aided Drug Discovery
Stephanie Staelens
Project Manager Early Drug Discovery
Annemarie Van Nieuwenhuijze
Head of Biology
Maarten Van Roy
Project Manager

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.